- Switching to systemic therapy after locoregionaltreatment failure: Definition and best timing
-
Ogasawara , Ooka Y, Koroki K, Maruta S, Kanzaki H, Kanayama K, Kobayashi , Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Suzuki E, Nakamoto S, Tawada A, Chiba T, Arai M, Kato J, Kato N
- KMID: 2500378
- Clin Mol Hepatol.
- 2020 Apr;26(2):155-162.
- doi: 10.3350/cmh.2019.0021n
In patients with unresectable hepatocellular carcinoma (HCC) without both macrovascular invasion and extrahepatic metastasis, the initial treatment choice recommended is transarterial chemoembolization (TACE). Before sorafenib came into wide use, TACE... -
- CITED
-
- Close
- SHARE
-
- Close
